PHARMABCINE
Updated 49 days ago
2F, Research Building 2, 70, Yuseong-daero 1689 beon-gil, Yuseong-gu, Daejeon, 34047, Republic of Korea
Our goal is to license-out the novel antibody candidates such as olinvacimab, PMC-309, PMC-403, and PMC-402 to global biopharmas...
Our mission is to contribute to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs...
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs.
Also known as: PharmAbcine Inc.